Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
JMIR Research Protocols
|
August 18, 2025
Best Practice Guidance for Male Individuals Using Anabolic Androgenic Steroids in Recreational Sports Within Primary Care: Protocol for a Modified Delphi Consensus Study
Raphael Magnolini, Oliver Senn, Stefan Neuner-Jehle, et al.
Swiss Medical Weekly
|
February 7, 2015
Hepatitis C: a changing epidemic
Gilles Wandeler, Jean-François Dufour, Philip Bruggmann, et al.
European Journal of Gastroenterology & Hepatology
|
April 11, 2013
Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis
Nathalie Brunner, Oliver Senn, Thomas Rosemann, et al.
The International Journal on Drug Policy
|
February 25, 2023
Substances from unregulated drug markets - A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)
Raphael Magnolini, Martina Schneider, Dominique Schori, et al.
Swiss Medical Weekly
|
September 11, 2013
QTc prolongation in methadone maintenance--the role of HCV infection
Najibulah Gholami, Lukas Boesch, Luis Falcato, et al.
BMC Public Health
|
July 16, 2022
Fake anabolic androgenic steroids on the black market - a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature
Raphael Magnolini, Luis Falcato, Alessio Cremonesi, et al.
Harm Reduction Journal
|
June 8, 2025
Evaluation of implementing drug checking services for anabolic androgenic steroids in Switzerland: a pilot study
Raphael Magnolini, Michel Kaeppeli, Dominique Schori, et al.
Swiss Medical Weekly
|
March 25, 2019
Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland
Sarah Blach, Christian Schaetti, Philip Bruggmann, et al.
The International Journal on Drug Policy
|
April 19, 2023
Corrigendum to 'Substances from unregulated drug markets - A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)' [Volume 114, April 2023, 103972]
Raphael Magnolini, Martina Schneider, Dominique Schori, et al.
Addictive Behaviors
|
March 7, 2025
Commentary on : Prior use of smoking cessation products among smokers willing to quit smoking who have substance use problems
Stéphanie Baggio, Anna Schoeni, Philip Bruggmann, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
JMIR Research Protocols
|
August 18, 2025
Best Practice Guidance for Male Individuals Using Anabolic Androgenic Steroids in Recreational Sports Within Primary Care: Protocol for a Modified Delphi Consensus Study
Raphael Magnolini, Oliver Senn, Stefan Neuner-Jehle, et al.
Swiss Medical Weekly
|
February 7, 2015
Hepatitis C: a changing epidemic
Gilles Wandeler, Jean-François Dufour, Philip Bruggmann, et al.
European Journal of Gastroenterology & Hepatology
|
April 11, 2013
Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis
Nathalie Brunner, Oliver Senn, Thomas Rosemann, et al.
The International Journal on Drug Policy
|
February 25, 2023
Substances from unregulated drug markets - A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)
Raphael Magnolini, Martina Schneider, Dominique Schori, et al.
Swiss Medical Weekly
|
September 11, 2013
QTc prolongation in methadone maintenance--the role of HCV infection
Najibulah Gholami, Lukas Boesch, Luis Falcato, et al.
BMC Public Health
|
July 16, 2022
Fake anabolic androgenic steroids on the black market - a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature
Raphael Magnolini, Luis Falcato, Alessio Cremonesi, et al.
Harm Reduction Journal
|
June 8, 2025
Evaluation of implementing drug checking services for anabolic androgenic steroids in Switzerland: a pilot study
Raphael Magnolini, Michel Kaeppeli, Dominique Schori, et al.
Swiss Medical Weekly
|
March 25, 2019
Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland
Sarah Blach, Christian Schaetti, Philip Bruggmann, et al.
The International Journal on Drug Policy
|
April 19, 2023
Corrigendum to 'Substances from unregulated drug markets - A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)' [Volume 114, April 2023, 103972]
Raphael Magnolini, Martina Schneider, Dominique Schori, et al.
Addictive Behaviors
|
March 7, 2025
Commentary on : Prior use of smoking cessation products among smokers willing to quit smoking who have substance use problems
Stéphanie Baggio, Anna Schoeni, Philip Bruggmann, et al.
Page
of 9